Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicity

20 Apr 2023

Abstract excerpt

The World Health Organization (WHO) stated that ensuring access to effective and optimal treatment is a key component to eradicate tuberculosis (TB) through the End TB Strategy. Personalized medicine that depends on the genetic profile of an individual is one way to optimize treatment. It is necessary because of diverse drug responses related to the variation in human DNA, such as single-nucleotide polymorphisms...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Mycobacterium research and diagnosis
Share to Tuberculosis Research and Epidemiology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37152993
DOI: 10.3389/fgene.2023.1118102

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphism related to ethambutol outcomes and susceptibility to toxicityPMID 37152993Read ↗

Genetic polymorphisms and adverse reactions to antituberculosis therapySemantic proximity Read ↗

Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis.Semantic proximity Read ↗

Adverse Drug Reactions to Anti-TB Drugs: Pharmacogenomics Perspective for Identification of Host Genetic Markers.Semantic proximity Read ↗

Transporter and metabolizer gene polymorphisms affect fluoroquinolone pharmacokinetic parametersSemantic proximity Read ↗

Pharmacogenetic Study of Anti-TB Drugs in the Native Ancestry Peruvian Population.Semantic proximity Read ↗

Association of variants within the <i>GST</i> and other genes with anti-tubercular agents related toxicity: a systematic review and meta-analysisSemantic proximity Read ↗

Improving the reporting of pharmacogenetic studies to facilitate evidence synthesis : anti-tuberculosis drug-related toxicity as an exampleSemantic proximity Read ↗

Frequency of mutational changes in the embB among the ethambutol-resistant strains of Mycobacterium tuberculosis in Iran.Semantic proximity Read ↗

Exploring Variability in Rifampicin Plasma Exposure and Development of Anti-Tuberculosis Drug-Induced Liver Injury among Patients with Pulmonary Tuberculosis from the Pharmacogenetic PerspectiveSemantic proximity Read ↗

Genome-wide association and replication study of anti-tuberculosis drugs-induced liver toxicitySemantic proximity Read ↗

Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohortSemantic proximity Read ↗

Human genetic factors in tuberculosis: an update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.